Corrigenda to Phase I/IIa study evaluating the safety, efficacy, pharmacokinetics, and pharmacodynamics of lucitanib in advanced solid tumors [Ann Oncol, 25 (2014) 2244-2251] DOI: 10.1093/annonc/mdu390

J. C. Soria; F. Debraud; R. Bahleda; B. Adamo; F. Andre; R. Dienstmann; A. Delmonte; R. Cereda; J. Isaacson; J. Litten; A. Allen; F. Dubois; C. Saba; R. Robert; M. D'incalci; M. Zucchetti; M. G. Camboni; J. Tabernero

doi:10.1093/annonc/mdu547

Corrigenda to Phase I/IIa study evaluating the safety, efficacy, pharmacokinetics, and pharmacodynamics of lucitanib in advanced solid tumors [Ann Oncol, 25 (2014) 2244-2251] DOI: 10.1093/annonc/mdu390

J. C. Soria, F. Debraud, R. Bahleda, B. Adamo, F. Andre, R. Dienstmann, A. Delmonte, R. Cereda, J. Isaacson, J. Litten, A. Allen, F. Dubois, C. Saba, R. Robert, M. D'incalci, M. Zucchetti, M. G. Camboni, J. Tabernero

Research output: Contribution to journal › Article › peer-review

Original language	English
Article number	mdu547
Pages (from-to)	445
Number of pages	1
Journal	Annals of Oncology
Volume	26
Issue number	2
DOIs	https://doi.org/10.1093/annonc/mdu547
Publication status	Published - Feb 1 2015

ASJC Scopus subject areas

Oncology
Hematology

Access to Document

10.1093/annonc/mdu547

Cite this

Soria, J. C., Debraud, F., Bahleda, R., Adamo, B., Andre, F., Dienstmann, R., Delmonte, A., Cereda, R., Isaacson, J., Litten, J., Allen, A., Dubois, F., Saba, C., Robert, R., D'incalci, M., Zucchetti, M., Camboni, M. G., & Tabernero, J. (2015). Corrigenda to Phase I/IIa study evaluating the safety, efficacy, pharmacokinetics, and pharmacodynamics of lucitanib in advanced solid tumors [Ann Oncol, 25 (2014) 2244-2251] DOI: 10.1093/annonc/mdu390. Annals of Oncology, 26(2), 445. [mdu547]. https://doi.org/10.1093/annonc/mdu547

Corrigenda to Phase I/IIa study evaluating the safety, efficacy, pharmacokinetics, and pharmacodynamics of lucitanib in advanced solid tumors [Ann Oncol, 25 (2014) 2244-2251] DOI : 10.1093/annonc/mdu390. / Soria, J. C.; Debraud, F.; Bahleda, R.; Adamo, B.; Andre, F.; Dienstmann, R.; Delmonte, A.; Cereda, R.; Isaacson, J.; Litten, J.; Allen, A.; Dubois, F.; Saba, C.; Robert, R.; D'incalci, M.; Zucchetti, M.; Camboni, M. G.; Tabernero, J.

In: Annals of Oncology, Vol. 26, No. 2, mdu547, 01.02.2015, p. 445.

Research output: Contribution to journal › Article › peer-review

Soria, JC, Debraud, F, Bahleda, R, Adamo, B, Andre, F, Dienstmann, R, Delmonte, A, Cereda, R, Isaacson, J, Litten, J, Allen, A, Dubois, F, Saba, C, Robert, R, D'incalci, M , Zucchetti, M, Camboni, MG & Tabernero, J 2015, 'Corrigenda to Phase I/IIa study evaluating the safety, efficacy, pharmacokinetics, and pharmacodynamics of lucitanib in advanced solid tumors [Ann Oncol, 25 (2014) 2244-2251] DOI: 10.1093/annonc/mdu390', Annals of Oncology, vol. 26, no. 2, mdu547, pp. 445. https://doi.org/10.1093/annonc/mdu547

Soria, J. C. ; Debraud, F. ; Bahleda, R. ; Adamo, B. ; Andre, F. ; Dienstmann, R. ; Delmonte, A. ; Cereda, R. ; Isaacson, J. ; Litten, J. ; Allen, A. ; Dubois, F. ; Saba, C. ; Robert, R. ; D'incalci, M. ; Zucchetti, M. ; Camboni, M. G. ; Tabernero, J. / Corrigenda to Phase I/IIa study evaluating the safety, efficacy, pharmacokinetics, and pharmacodynamics of lucitanib in advanced solid tumors [Ann Oncol, 25 (2014) 2244-2251] DOI : 10.1093/annonc/mdu390. In: Annals of Oncology. 2015 ; Vol. 26, No. 2. pp. 445.

@article{8fa58b5a4f0d452fb888cfcc240d3abb,

title = "Corrigenda to Phase I/IIa study evaluating the safety, efficacy, pharmacokinetics, and pharmacodynamics of lucitanib in advanced solid tumors [Ann Oncol, 25 (2014) 2244-2251] DOI: 10.1093/annonc/mdu390",

author = "Soria, {J. C.} and F. Debraud and R. Bahleda and B. Adamo and F. Andre and R. Dienstmann and A. Delmonte and R. Cereda and J. Isaacson and J. Litten and A. Allen and F. Dubois and C. Saba and R. Robert and M. D'incalci and M. Zucchetti and Camboni, {M. G.} and J. Tabernero",

year = "2015",

month = feb,

day = "1",

doi = "10.1093/annonc/mdu547",

language = "English",

volume = "26",

pages = "445",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "NLM (Medline)",

number = "2",

}

TY - JOUR

T1 - Corrigenda to Phase I/IIa study evaluating the safety, efficacy, pharmacokinetics, and pharmacodynamics of lucitanib in advanced solid tumors [Ann Oncol, 25 (2014) 2244-2251] DOI

T2 - 10.1093/annonc/mdu390

AU - Soria, J. C.

AU - Debraud, F.

AU - Bahleda, R.

AU - Adamo, B.

AU - Andre, F.

AU - Dienstmann, R.

AU - Delmonte, A.

AU - Cereda, R.

AU - Isaacson, J.

AU - Litten, J.

AU - Allen, A.

AU - Dubois, F.

AU - Saba, C.

AU - Robert, R.

AU - D'incalci, M.

AU - Zucchetti, M.

AU - Camboni, M. G.

AU - Tabernero, J.

PY - 2015/2/1

Y1 - 2015/2/1

UR - http://www.scopus.com/inward/record.url?scp=84925301725&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84925301725&partnerID=8YFLogxK

U2 - 10.1093/annonc/mdu547

DO - 10.1093/annonc/mdu547

M3 - Article

AN - SCOPUS:84925301725

VL - 26

SP - 445

JO - Annals of Oncology

JF - Annals of Oncology

SN - 0923-7534

IS - 2

M1 - mdu547

ER -